Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Stevanato Group S.p.A. (STVN : NYSE)

• Company Description    Stevanato Group S.p.A. is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. Stevanato Group S.p.A. is based in PIOMBINO DESE, Italy. Number of Employees: 6,010

• Price / Volume Information    Yesterday's Closing Price: $18.01 Daily Weekly Monthly 20 Day Moving Average: 525,916 shares Shares Outstanding: 302.84 (millions) Market Capitalization: $5,454.20 (millions) Beta: 0.75 52 Week High: $28.00 52 Week Low: $12.89 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 10.90% 5.48% 12 Week 17.64% 8.75% Year To Date -10.49% -18.43%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL PIOMBINO DESE (PD) VIA MOLINELLA 17 - PADUA,L6 35017 ITA ph: 39049931811 fax: - lisa.miles@stevanatogroup.com http://www.stevanatogroup.com/en

• General Corporate Information    Officers Franco Stevanato - Chief Executive Officer and Chairman Sergio Stevanato - Chairman Ugo Gay - Chief Operating Officer Marco Dal Lago - Chief Financial Officer Karen Flynn - Director Peer Information Stevanato Group S.p.A. (GSAC) Stevanato Group S.p.A. (CASIF) Stevanato Group S.p.A. (ALCD.) Stevanato Group S.p.A. (OMNN) Stevanato Group S.p.A. (CGPI.) Stevanato Group S.p.A. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: T9224W109 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/04/26 Share - Related Items Shares Outstanding: 302.84 Most Recent Split Date: (:1) Beta: 0.75 Market Capitalization: $5,454.20 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.14 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.68 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 15.87% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/04/26

• Fundamental Ratios P/E Current FY Estimate: 26.33 Trailing 12 Months: 29.05 PEG Ratio: 1.66 Price Ratios Price/Book: 3.04 Price/Cash Flow: 20.42 Price / Sales: 3.91 EPS Growth vs. Year Ago Period: 18.18% vs. Previous Quarter: -38.10% Sales Growth vs. Year Ago Period: 18.61% vs. Previous Quarter: -20.63% ROE 03/31/26 - 10.27 12/31/25 - 10.44 09/30/25 - 10.52 ROA 03/31/26 - 6.08 12/31/25 - 6.22 09/30/25 - 6.32 Current Ratio 03/31/26 - 1.63 12/31/25 - 1.76 09/30/25 - 1.89 Quick Ratio 03/31/26 - 1.11 12/31/25 - 1.26 09/30/25 - 1.30 Operating Margin 03/31/26 - 12.40 12/31/25 - 12.50 09/30/25 - 12.75 Net Margin 03/31/26 - 11.76 12/31/25 - 11.83 09/30/25 - 11.99 Pre-Tax Margin 03/31/26 - 15.97 12/31/25 - 15.94 09/30/25 - 16.07 Book Value 03/31/26 - 5.92 12/31/25 - 5.55 09/30/25 - 5.55 Inventory Turnover 03/31/26 - 3.09 12/31/25 - 3.15 09/30/25 - 3.15 Debt-to-Equity 03/31/26 - 0.21 12/31/25 - 0.23 09/30/25 - 0.26 Debt-to-Capital 03/31/26 - 17.46 12/31/25 - 18.94 09/30/25 - 20.39

Powered by Zacks Investment Research ©